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Background: Urinary tract infections (UTI) are common world-
wide and affect all sexes and age groups. An estimated 20% or
more of the female population suffers from some form of UTIs
in their lifetime. Although antibiotics are the ﬁrst choice of treat-
ment for many urinary tract infections, antibiotic-resistant strains
of bacterial species commonly associated with UTIs, are increas-
ing worldwide. The purpose of this study was to determine the
pathogen antimicrobial sensitivity trends of bacterial pathogens
associated with UTIs.
Methods & Materials: A retrospective study was carried out on
bacteria isolated from the urine of patients at the BUTH laboratory
between January 2006 and December 2010.
Results: A total of 1611 pathogens have been found.The most
commonly isolated bacteria were Escherichia coli (876 strains),
Klebsiella Species (190 strains), Coagulase negative Staphylococcus
(114 strains), Streptococcus species (97 strains), Proteus species
(90 strains) and staphylococcus aureus (86 strains). Most of iso-
lateswere resistant toaminopenicillins (ampicillinandamoxicillin)
and to trimethoprim- sulfamethoxazole (TMP-SMZ). Strains were
rarely resistant to more expensive antibiotics (imipenem and cefo-
taxime). The most effective antibiotic to almost all isolates was
imipenem, which is not commonly used in treatment of UTIs in
Rwanda.
Conclusion: The rate of amoxicillin and trimethoprim-
sulfamethoxazole resistance to Enterobacteriaceae implies that
another antibiotic should be used for empirical treatment and that
there is a need for new generic drugs in Rwanda. Imipenem could
be included as a reasonable alternative for the therapy of UTIs in
Rwanda.
http://dx.doi.org/10.1016/j.ijid.2014.03.600
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Background: In aﬁve year period4505patients underwent gas-
troscopy in Endoscopic Unit of the Clinic and byopsy specimens
for determination of H. pylori infection were taken. Gender ratio
was 2663 (59,11%) female versus 1942 male patients (40,89%). All
gastric specimens were Gram stained, urease tested and cultivated
on Columbia agar enriched with supplement and 5% addition of
citrated equine blood. 56,93% specimens were H. pylori positive
and 43,07% negative. Urease positive specimens were E tested on
four antimicrobials - amoxicillin,clarithromycin, tetracycline and
metronidazole. Isolation of H. pylori and antimicrobial susceptibil-
ity testing were successful in 1013 specimens (39,49%).
Methods&Materials: All gastric specimenswereGramstained,
urease tested and cultivated on Columbia agar enriched with
supplement and 5% addition of citrated equine blood. 56,93%
specimens were H. pylori positive and 43,07% negative. Urease
positive specimens were E tested on four antimicrobials - amox-
icillin,clarithromycin, tetracycline and metronidazole.
Results: Isolation of H. pylori and antimicrobial susceptibil-
ity testing were successful in 1013 specimens (39,49%). Not a
single isolated strain was resistant to amoxicillin, resistance to
tetracycline varied from 4,77% to 8, 22% and showed no ten-
dency of increase from 2008 to 2012. Metronidazole resistance
decreased from 29,00% in 2008 to 22,83% in 2013. Percentage of
clarithromycin resistant strains rose from 8,25% in 2008 to 19,75%
in 2012.
Conclusion: We attribute the rise of clarithromycin resistance
to overall use of the drug in triple eradication regimens together
with amoxicillin and proton pump inhibitors. Metronidazole resis-
tance in our patients in late 90s was about 65% due to abuse of the
drug in multiple eradication attempts without prior susceptibil-
ity testing. Further administration of clarithromycin in eradication
regimens should be considered and indications should be very
strict. Eithermetronidazole again or levoﬂoxacine can replace clar-
ithromycin but after several years of unprudent administration we
can expect that percentage of resistant strains will prohibit the use
of those agents as well.
http://dx.doi.org/10.1016/j.ijid.2014.03.601
